Search earnings tickers

GILD

2026Q1AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-05-07 · Fiscal end 2026-03-31 · Features as of 2026-05-07

← Earnings history

Street

Consensus EPS1.91

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.6%

IV front—

P/C full—

P/C front—

Features as of2026-05-07

Run-up

Close—

Ret 5d+2.5%

Ret 10d+0.3%

Ret 20d-5.7%

Ret 30d-3.0%

Print

Actual EPS

2.03Beat

Estimated EPS1.91

Actual revenue

7.0B

Surprise %+6.3%

Beat / missBeat

Beat streak 44

Beat streak 88

Reaction

1-day stock reaction+1.0%

Implied vs actual

Implied 2.6%Actual 3.0%

Gap reaction-3.0%

Day result-2.0%

Next-day upYes

Realized / IV1.17×

Post tape

Post 5d-1.3%

Post 10d+2.3%

Post volume10.3M

Vol ×10d1.59×

Vol ×20d1.77×

Post range3.3%